Antimicrobial Resistance Trends in Post-2020 Clinical Isolates
Clinical Endocrinology and Metabolism · 30.10.2025 · 04 (05) · 01-04
DOI: 10.31579/2834-8761/097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology and Metabolism, online erschienen am 30.10.2025. Verfasst von Kavita Sharma *.
Abstract (Originalsprache)
The emergence and escalation of antimicrobial resistance (AMR) in clinical isolates present a formidable challenge to global health systems. This study provides an in-depth evaluation of AMR trends in post-2020 clinical isolates, assessing prevalence patterns, resistance mechanisms, and their implications for patient outcomes and healthcare delivery. Utilizing a mixed-methods approach, combining quantitative laboratory analyses and qualitative insights from healthcare providers, the research identifies critical trends, highlights emerging resistance hotspots, and evaluates the effectiveness of stewardship interventions. Findings reveal increasing resistance among key bacterial pathogens to first-line and second-line antimicrobial agents, emphasizing the urgent need for enhanced surveillance, tailored therapeutic strategies, and integrated public health policies. The study underscores the importance of continuous monitoring, rapid diagnostic deployment, and evidence-based decision-making to mitigate the rising threat of AMR in the post-pandemic healthcare landscape.
Zitieren
APA
*, K. S. (2025). Antimicrobial Resistance Trends in Post-2020 Clinical Isolates. Clinical Endocrinology and Metabolism, 04(05), 01-04. https://doi.org/10.31579/2834-8761/097
Vancouver
* KS. Antimicrobial Resistance Trends in Post-2020 Clinical Isolates. Clinical Endocrinology and Metabolism. 2025;04(05):01-04. doi:10.31579/2834-8761/097
BibTeX
@article{2025,
author = {*, Kavita Sharma},
title = {Antimicrobial Resistance Trends in Post-2020 Clinical Isolates},
journal = {Clinical Endocrinology and Metabolism},
year = {2025},
volume = {04},
number = {05},
pages = {01--04},
doi = {10.31579/2834-8761/097}
}
EUVIMED